Global Minimal Residual Disease Testing Market Research Report 2026(Status and Outlook)
The global Minimal Residual Disease Testing market size was estimated at USD 2407.2 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 15.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Minimal Residual Disease Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Minimal Residual Disease Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Minimal Residual Disease Testing market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Minimal Residual Disease Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Minimal Residual Disease Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
This report offers a comprehensive and in-depth analysis of the global Minimal Residual Disease Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Minimal Residual Disease Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Minimal Residual Disease Testing market.
Global Minimal Residual Disease Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Adaptive Biotechnologies
- ArcherDX
- ARUP Laboratories
- Asuragen
- F. Hoffmann-La Roche
- Guardant Health
- Labcorp
- NeoGenomics Laboratories
- Sysmex Corporation
Market Segmentation (by Type)
- Flow Cytometry
- Polymerase Chain Reaction
Market Segmentation (by Application)
- Hospitals and Specialty Clinics
- Diagnostic Laboratories
- Academic and Research Institutes
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Minimal Residual Disease Testing Market
Overview of the regional outlook of the Minimal Residual Disease Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Minimal Residual Disease Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Minimal Residual Disease Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Minimal Residual Disease Testing
1.2 Key Market Segments
1.2.1 Minimal Residual Disease Testing Segment by Type
1.2.2 Minimal Residual Disease Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MINIMAL RESIDUAL DISEASE TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Minimal Residual Disease Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Minimal Residual Disease Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MINIMAL RESIDUAL DISEASE TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Minimal Residual Disease Testing Product Life Cycle
3.3 Global Minimal Residual Disease Testing Sales by Manufacturers (2020-2025)
3.4 Global Minimal Residual Disease Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Minimal Residual Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Minimal Residual Disease Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Minimal Residual Disease Testing Market Competitive Situation and Trends
3.8.1 Minimal Residual Disease Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Minimal Residual Disease Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MINIMAL RESIDUAL DISEASE TESTING INDUSTRY CHAIN ANALYSIS
4.1 Minimal Residual Disease Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MINIMAL RESIDUAL DISEASE TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Minimal Residual Disease Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Minimal Residual Disease Testing Market
5.7 ESG Ratings of Leading Companies
6 MINIMAL RESIDUAL DISEASE TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Minimal Residual Disease Testing Sales Market Share by Type (2020-2025)
6.3 Global Minimal Residual Disease Testing Market Size by Type (2020-2025)
6.4 Global Minimal Residual Disease Testing Price by Type (2020-2025)
7 MINIMAL RESIDUAL DISEASE TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Minimal Residual Disease Testing Market Sales by Application (2020-2025)
7.3 Global Minimal Residual Disease Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Minimal Residual Disease Testing Sales Growth Rate by Application (2020-2025)
8 MINIMAL RESIDUAL DISEASE TESTING MARKET SALES BY REGION
8.1 Global Minimal Residual Disease Testing Sales by Region
8.1.1 Global Minimal Residual Disease Testing Sales by Region
8.1.2 Global Minimal Residual Disease Testing Sales Market Share by Region
8.2 Global Minimal Residual Disease Testing Market Size by Region
8.2.1 Global Minimal Residual Disease Testing Market Size by Region
8.2.2 Global Minimal Residual Disease Testing Market Size by Region
8.3 North America
8.3.1 North America Minimal Residual Disease Testing Sales by Country
8.3.2 North America Minimal Residual Disease Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Minimal Residual Disease Testing Sales by Country
8.4.2 Europe Minimal Residual Disease Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Minimal Residual Disease Testing Sales by Region
8.5.2 Asia Pacific Minimal Residual Disease Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Minimal Residual Disease Testing Sales by Country
8.6.2 South America Minimal Residual Disease Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Minimal Residual Disease Testing Sales by Region
8.7.2 Middle East and Africa Minimal Residual Disease Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MINIMAL RESIDUAL DISEASE TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Minimal Residual Disease Testing by Region(2020-2025)
9.2 Global Minimal Residual Disease Testing Revenue Market Share by Region (2020-2025)
9.3 Global Minimal Residual Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Minimal Residual Disease Testing Production
9.4.1 North America Minimal Residual Disease Testing Production Growth Rate (2020-2025)
9.4.2 North America Minimal Residual Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Minimal Residual Disease Testing Production
9.5.1 Europe Minimal Residual Disease Testing Production Growth Rate (2020-2025)
9.5.2 Europe Minimal Residual Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Minimal Residual Disease Testing Production (2020-2025)
9.6.1 Japan Minimal Residual Disease Testing Production Growth Rate (2020-2025)
9.6.2 Japan Minimal Residual Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Minimal Residual Disease Testing Production (2020-2025)
9.7.1 China Minimal Residual Disease Testing Production Growth Rate (2020-2025)
9.7.2 China Minimal Residual Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Adaptive Biotechnologies
10.1.1 Adaptive Biotechnologies Basic Information
10.1.2 Adaptive Biotechnologies Minimal Residual Disease Testing Product Overview
10.1.3 Adaptive Biotechnologies Minimal Residual Disease Testing Product Market Performance
10.1.4 Adaptive Biotechnologies Business Overview
10.1.5 Adaptive Biotechnologies SWOT Analysis
10.1.6 Adaptive Biotechnologies Recent Developments
10.2 ArcherDX
10.2.1 ArcherDX Basic Information
10.2.2 ArcherDX Minimal Residual Disease Testing Product Overview
10.2.3 ArcherDX Minimal Residual Disease Testing Product Market Performance
10.2.4 ArcherDX Business Overview
10.2.5 ArcherDX SWOT Analysis
10.2.6 ArcherDX Recent Developments
10.3 ARUP Laboratories
10.3.1 ARUP Laboratories Basic Information
10.3.2 ARUP Laboratories Minimal Residual Disease Testing Product Overview
10.3.3 ARUP Laboratories Minimal Residual Disease Testing Product Market Performance
10.3.4 ARUP Laboratories Business Overview
10.3.5 ARUP Laboratories SWOT Analysis
10.3.6 ARUP Laboratories Recent Developments
10.4 Asuragen
10.4.1 Asuragen Basic Information
10.4.2 Asuragen Minimal Residual Disease Testing Product Overview
10.4.3 Asuragen Minimal Residual Disease Testing Product Market Performance
10.4.4 Asuragen Business Overview
10.4.5 Asuragen Recent Developments
10.5 F. Hoffmann-La Roche
10.5.1 F. Hoffmann-La Roche Basic Information
10.5.2 F. Hoffmann-La Roche Minimal Residual Disease Testing Product Overview
10.5.3 F. Hoffmann-La Roche Minimal Residual Disease Testing Product Market Performance
10.5.4 F. Hoffmann-La Roche Business Overview
10.5.5 F. Hoffmann-La Roche Recent Developments
10.6 Guardant Health
10.6.1 Guardant Health Basic Information
10.6.2 Guardant Health Minimal Residual Disease Testing Product Overview
10.6.3 Guardant Health Minimal Residual Disease Testing Product Market Performance
10.6.4 Guardant Health Business Overview
10.6.5 Guardant Health Recent Developments
10.7 Labcorp
10.7.1 Labcorp Basic Information
10.7.2 Labcorp Minimal Residual Disease Testing Product Overview
10.7.3 Labcorp Minimal Residual Disease Testing Product Market Performance
10.7.4 Labcorp Business Overview
10.7.5 Labcorp Recent Developments
10.8 NeoGenomics Laboratories
10.8.1 NeoGenomics Laboratories Basic Information
10.8.2 NeoGenomics Laboratories Minimal Residual Disease Testing Product Overview
10.8.3 NeoGenomics Laboratories Minimal Residual Disease Testing Product Market Performance
10.8.4 NeoGenomics Laboratories Business Overview
10.8.5 NeoGenomics Laboratories Recent Developments
10.9 Sysmex Corporation
10.9.1 Sysmex Corporation Basic Information
10.9.2 Sysmex Corporation Minimal Residual Disease Testing Product Overview
10.9.3 Sysmex Corporation Minimal Residual Disease Testing Product Market Performance
10.9.4 Sysmex Corporation Business Overview
10.9.5 Sysmex Corporation Recent Developments
11 MINIMAL RESIDUAL DISEASE TESTING MARKET FORECAST BY REGION
11.1 Global Minimal Residual Disease Testing Market Size Forecast
11.2 Global Minimal Residual Disease Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Minimal Residual Disease Testing Market Size Forecast by Country
11.2.3 Asia Pacific Minimal Residual Disease Testing Market Size Forecast by Region
11.2.4 South America Minimal Residual Disease Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Minimal Residual Disease Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Minimal Residual Disease Testing Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Minimal Residual Disease Testing by Type (2026-2035)
12.1.2 Global Minimal Residual Disease Testing Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Minimal Residual Disease Testing by Type (2026-2035)
12.2 Global Minimal Residual Disease Testing Market Forecast by Application (2026-2035)
12.2.1 Global Minimal Residual Disease Testing Sales (K Units) Forecast by Application
12.2.2 Global Minimal Residual Disease Testing Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Minimal Residual Disease Testing
1.2 Key Market Segments
1.2.1 Minimal Residual Disease Testing Segment by Type
1.2.2 Minimal Residual Disease Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MINIMAL RESIDUAL DISEASE TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Minimal Residual Disease Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Minimal Residual Disease Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MINIMAL RESIDUAL DISEASE TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Minimal Residual Disease Testing Product Life Cycle
3.3 Global Minimal Residual Disease Testing Sales by Manufacturers (2020-2025)
3.4 Global Minimal Residual Disease Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Minimal Residual Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Minimal Residual Disease Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Minimal Residual Disease Testing Market Competitive Situation and Trends
3.8.1 Minimal Residual Disease Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Minimal Residual Disease Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MINIMAL RESIDUAL DISEASE TESTING INDUSTRY CHAIN ANALYSIS
4.1 Minimal Residual Disease Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MINIMAL RESIDUAL DISEASE TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Minimal Residual Disease Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Minimal Residual Disease Testing Market
5.7 ESG Ratings of Leading Companies
6 MINIMAL RESIDUAL DISEASE TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Minimal Residual Disease Testing Sales Market Share by Type (2020-2025)
6.3 Global Minimal Residual Disease Testing Market Size by Type (2020-2025)
6.4 Global Minimal Residual Disease Testing Price by Type (2020-2025)
7 MINIMAL RESIDUAL DISEASE TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Minimal Residual Disease Testing Market Sales by Application (2020-2025)
7.3 Global Minimal Residual Disease Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Minimal Residual Disease Testing Sales Growth Rate by Application (2020-2025)
8 MINIMAL RESIDUAL DISEASE TESTING MARKET SALES BY REGION
8.1 Global Minimal Residual Disease Testing Sales by Region
8.1.1 Global Minimal Residual Disease Testing Sales by Region
8.1.2 Global Minimal Residual Disease Testing Sales Market Share by Region
8.2 Global Minimal Residual Disease Testing Market Size by Region
8.2.1 Global Minimal Residual Disease Testing Market Size by Region
8.2.2 Global Minimal Residual Disease Testing Market Size by Region
8.3 North America
8.3.1 North America Minimal Residual Disease Testing Sales by Country
8.3.2 North America Minimal Residual Disease Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Minimal Residual Disease Testing Sales by Country
8.4.2 Europe Minimal Residual Disease Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Minimal Residual Disease Testing Sales by Region
8.5.2 Asia Pacific Minimal Residual Disease Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Minimal Residual Disease Testing Sales by Country
8.6.2 South America Minimal Residual Disease Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Minimal Residual Disease Testing Sales by Region
8.7.2 Middle East and Africa Minimal Residual Disease Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MINIMAL RESIDUAL DISEASE TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Minimal Residual Disease Testing by Region(2020-2025)
9.2 Global Minimal Residual Disease Testing Revenue Market Share by Region (2020-2025)
9.3 Global Minimal Residual Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Minimal Residual Disease Testing Production
9.4.1 North America Minimal Residual Disease Testing Production Growth Rate (2020-2025)
9.4.2 North America Minimal Residual Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Minimal Residual Disease Testing Production
9.5.1 Europe Minimal Residual Disease Testing Production Growth Rate (2020-2025)
9.5.2 Europe Minimal Residual Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Minimal Residual Disease Testing Production (2020-2025)
9.6.1 Japan Minimal Residual Disease Testing Production Growth Rate (2020-2025)
9.6.2 Japan Minimal Residual Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Minimal Residual Disease Testing Production (2020-2025)
9.7.1 China Minimal Residual Disease Testing Production Growth Rate (2020-2025)
9.7.2 China Minimal Residual Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Adaptive Biotechnologies
10.1.1 Adaptive Biotechnologies Basic Information
10.1.2 Adaptive Biotechnologies Minimal Residual Disease Testing Product Overview
10.1.3 Adaptive Biotechnologies Minimal Residual Disease Testing Product Market Performance
10.1.4 Adaptive Biotechnologies Business Overview
10.1.5 Adaptive Biotechnologies SWOT Analysis
10.1.6 Adaptive Biotechnologies Recent Developments
10.2 ArcherDX
10.2.1 ArcherDX Basic Information
10.2.2 ArcherDX Minimal Residual Disease Testing Product Overview
10.2.3 ArcherDX Minimal Residual Disease Testing Product Market Performance
10.2.4 ArcherDX Business Overview
10.2.5 ArcherDX SWOT Analysis
10.2.6 ArcherDX Recent Developments
10.3 ARUP Laboratories
10.3.1 ARUP Laboratories Basic Information
10.3.2 ARUP Laboratories Minimal Residual Disease Testing Product Overview
10.3.3 ARUP Laboratories Minimal Residual Disease Testing Product Market Performance
10.3.4 ARUP Laboratories Business Overview
10.3.5 ARUP Laboratories SWOT Analysis
10.3.6 ARUP Laboratories Recent Developments
10.4 Asuragen
10.4.1 Asuragen Basic Information
10.4.2 Asuragen Minimal Residual Disease Testing Product Overview
10.4.3 Asuragen Minimal Residual Disease Testing Product Market Performance
10.4.4 Asuragen Business Overview
10.4.5 Asuragen Recent Developments
10.5 F. Hoffmann-La Roche
10.5.1 F. Hoffmann-La Roche Basic Information
10.5.2 F. Hoffmann-La Roche Minimal Residual Disease Testing Product Overview
10.5.3 F. Hoffmann-La Roche Minimal Residual Disease Testing Product Market Performance
10.5.4 F. Hoffmann-La Roche Business Overview
10.5.5 F. Hoffmann-La Roche Recent Developments
10.6 Guardant Health
10.6.1 Guardant Health Basic Information
10.6.2 Guardant Health Minimal Residual Disease Testing Product Overview
10.6.3 Guardant Health Minimal Residual Disease Testing Product Market Performance
10.6.4 Guardant Health Business Overview
10.6.5 Guardant Health Recent Developments
10.7 Labcorp
10.7.1 Labcorp Basic Information
10.7.2 Labcorp Minimal Residual Disease Testing Product Overview
10.7.3 Labcorp Minimal Residual Disease Testing Product Market Performance
10.7.4 Labcorp Business Overview
10.7.5 Labcorp Recent Developments
10.8 NeoGenomics Laboratories
10.8.1 NeoGenomics Laboratories Basic Information
10.8.2 NeoGenomics Laboratories Minimal Residual Disease Testing Product Overview
10.8.3 NeoGenomics Laboratories Minimal Residual Disease Testing Product Market Performance
10.8.4 NeoGenomics Laboratories Business Overview
10.8.5 NeoGenomics Laboratories Recent Developments
10.9 Sysmex Corporation
10.9.1 Sysmex Corporation Basic Information
10.9.2 Sysmex Corporation Minimal Residual Disease Testing Product Overview
10.9.3 Sysmex Corporation Minimal Residual Disease Testing Product Market Performance
10.9.4 Sysmex Corporation Business Overview
10.9.5 Sysmex Corporation Recent Developments
11 MINIMAL RESIDUAL DISEASE TESTING MARKET FORECAST BY REGION
11.1 Global Minimal Residual Disease Testing Market Size Forecast
11.2 Global Minimal Residual Disease Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Minimal Residual Disease Testing Market Size Forecast by Country
11.2.3 Asia Pacific Minimal Residual Disease Testing Market Size Forecast by Region
11.2.4 South America Minimal Residual Disease Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Minimal Residual Disease Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Minimal Residual Disease Testing Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Minimal Residual Disease Testing by Type (2026-2035)
12.1.2 Global Minimal Residual Disease Testing Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Minimal Residual Disease Testing by Type (2026-2035)
12.2 Global Minimal Residual Disease Testing Market Forecast by Application (2026-2035)
12.2.1 Global Minimal Residual Disease Testing Sales (K Units) Forecast by Application
12.2.2 Global Minimal Residual Disease Testing Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Minimal Residual Disease Testing Market Size by Type (M USD)
Table 4. Global Minimal Residual Disease Testing Market Size by Application
Table 5. Minimal Residual Disease Testing Market Size Comparison by Region (M USD)
Table 6. Global Minimal Residual Disease Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Minimal Residual Disease Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Minimal Residual Disease Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Minimal Residual Disease Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimal Residual Disease Testing as of 2025)
Table 11. Global Market Minimal Residual Disease Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Minimal Residual Disease Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Minimal Residual Disease Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Minimal Residual Disease Testing Sales by Type (K Units)
Table 27. Global Minimal Residual Disease Testing Market Size by Type (M USD)
Table 28. Global Minimal Residual Disease Testing Sales (K Units) by Type (2020-2025)
Table 29. Global Minimal Residual Disease Testing Sales Market Share by Type (2020-2025)
Table 30. Global Minimal Residual Disease Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global Minimal Residual Disease Testing Market Share by Type (2020-2025)
Table 32. Global Minimal Residual Disease Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Minimal Residual Disease Testing Sales (K Units) by Application
Table 34. Global Minimal Residual Disease Testing Market Size by Application
Table 35. Global Minimal Residual Disease Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global Minimal Residual Disease Testing Sales Market Share by Application (2020-2025)
Table 37. Global Minimal Residual Disease Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Minimal Residual Disease Testing Market Share by Application (2020-2025)
Table 39. Global Minimal Residual Disease Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global Minimal Residual Disease Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global Minimal Residual Disease Testing Sales Market Share by Region (2020-2025)
Table 42. Global Minimal Residual Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Minimal Residual Disease Testing Market Size by Region (2020-2025)
Table 44. North America Minimal Residual Disease Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America Minimal Residual Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Minimal Residual Disease Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Minimal Residual Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Minimal Residual Disease Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Minimal Residual Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Minimal Residual Disease Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America Minimal Residual Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Minimal Residual Disease Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Minimal Residual Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Minimal Residual Disease Testing Production (K Units) by Region(2020-2025)
Table 55. Global Minimal Residual Disease Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Minimal Residual Disease Testing Revenue Market Share by Region (2020-2025)
Table 57. Global Minimal Residual Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Minimal Residual Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Minimal Residual Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Minimal Residual Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Minimal Residual Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Adaptive Biotechnologies Basic Information
Table 63. Adaptive Biotechnologies Minimal Residual Disease Testing Product Overview
Table 64. Adaptive Biotechnologies Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Adaptive Biotechnologies Business Overview
Table 66. Adaptive Biotechnologies SWOT Analysis
Table 67. Adaptive Biotechnologies Recent Developments
Table 68. ArcherDX Basic Information
Table 69. ArcherDX Minimal Residual Disease Testing Product Overview
Table 70. ArcherDX Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. ArcherDX Business Overview
Table 72. ArcherDX SWOT Analysis
Table 73. ArcherDX Recent Developments
Table 74. ARUP Laboratories Basic Information
Table 75. ARUP Laboratories Minimal Residual Disease Testing Product Overview
Table 76. ARUP Laboratories Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. ARUP Laboratories Business Overview
Table 78. ARUP Laboratories SWOT Analysis
Table 79. ARUP Laboratories Recent Developments
Table 80. Asuragen Basic Information
Table 81. Asuragen Minimal Residual Disease Testing Product Overview
Table 82. Asuragen Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Asuragen Business Overview
Table 84. Asuragen Recent Developments
Table 85. F. Hoffmann-La Roche Basic Information
Table 86. F. Hoffmann-La Roche Minimal Residual Disease Testing Product Overview
Table 87. F. Hoffmann-La Roche Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. F. Hoffmann-La Roche Business Overview
Table 89. F. Hoffmann-La Roche Recent Developments
Table 90. Guardant Health Basic Information
Table 91. Guardant Health Minimal Residual Disease Testing Product Overview
Table 92. Guardant Health Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Guardant Health Business Overview
Table 94. Guardant Health Recent Developments
Table 95. Labcorp Basic Information
Table 96. Labcorp Minimal Residual Disease Testing Product Overview
Table 97. Labcorp Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Labcorp Business Overview
Table 99. Labcorp Recent Developments
Table 100. NeoGenomics Laboratories Basic Information
Table 101. NeoGenomics Laboratories Minimal Residual Disease Testing Product Overview
Table 102. NeoGenomics Laboratories Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. NeoGenomics Laboratories Business Overview
Table 104. NeoGenomics Laboratories Recent Developments
Table 105. Sysmex Corporation Basic Information
Table 106. Sysmex Corporation Minimal Residual Disease Testing Product Overview
Table 107. Sysmex Corporation Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Sysmex Corporation Business Overview
Table 109. Sysmex Corporation Recent Developments
Table 110. Global Minimal Residual Disease Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 111. Global Minimal Residual Disease Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Minimal Residual Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 113. North America Minimal Residual Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Minimal Residual Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 115. Europe Minimal Residual Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Minimal Residual Disease Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 117. Asia Pacific Minimal Residual Disease Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Minimal Residual Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 119. South America Minimal Residual Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Minimal Residual Disease Testing Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Minimal Residual Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Minimal Residual Disease Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 123. Global Minimal Residual Disease Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Minimal Residual Disease Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 125. Global Minimal Residual Disease Testing Sales (K Units) Forecast by Application (2026-2035)
Table 126. Global Minimal Residual Disease Testing Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Minimal Residual Disease Testing Market Size by Type (M USD)
Table 4. Global Minimal Residual Disease Testing Market Size by Application
Table 5. Minimal Residual Disease Testing Market Size Comparison by Region (M USD)
Table 6. Global Minimal Residual Disease Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Minimal Residual Disease Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Minimal Residual Disease Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Minimal Residual Disease Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Minimal Residual Disease Testing as of 2025)
Table 11. Global Market Minimal Residual Disease Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Minimal Residual Disease Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Minimal Residual Disease Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Minimal Residual Disease Testing Sales by Type (K Units)
Table 27. Global Minimal Residual Disease Testing Market Size by Type (M USD)
Table 28. Global Minimal Residual Disease Testing Sales (K Units) by Type (2020-2025)
Table 29. Global Minimal Residual Disease Testing Sales Market Share by Type (2020-2025)
Table 30. Global Minimal Residual Disease Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global Minimal Residual Disease Testing Market Share by Type (2020-2025)
Table 32. Global Minimal Residual Disease Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Minimal Residual Disease Testing Sales (K Units) by Application
Table 34. Global Minimal Residual Disease Testing Market Size by Application
Table 35. Global Minimal Residual Disease Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global Minimal Residual Disease Testing Sales Market Share by Application (2020-2025)
Table 37. Global Minimal Residual Disease Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Minimal Residual Disease Testing Market Share by Application (2020-2025)
Table 39. Global Minimal Residual Disease Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global Minimal Residual Disease Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global Minimal Residual Disease Testing Sales Market Share by Region (2020-2025)
Table 42. Global Minimal Residual Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Minimal Residual Disease Testing Market Size by Region (2020-2025)
Table 44. North America Minimal Residual Disease Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America Minimal Residual Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Minimal Residual Disease Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Minimal Residual Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Minimal Residual Disease Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Minimal Residual Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Minimal Residual Disease Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America Minimal Residual Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Minimal Residual Disease Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Minimal Residual Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Minimal Residual Disease Testing Production (K Units) by Region(2020-2025)
Table 55. Global Minimal Residual Disease Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Minimal Residual Disease Testing Revenue Market Share by Region (2020-2025)
Table 57. Global Minimal Residual Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Minimal Residual Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Minimal Residual Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Minimal Residual Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Minimal Residual Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Adaptive Biotechnologies Basic Information
Table 63. Adaptive Biotechnologies Minimal Residual Disease Testing Product Overview
Table 64. Adaptive Biotechnologies Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Adaptive Biotechnologies Business Overview
Table 66. Adaptive Biotechnologies SWOT Analysis
Table 67. Adaptive Biotechnologies Recent Developments
Table 68. ArcherDX Basic Information
Table 69. ArcherDX Minimal Residual Disease Testing Product Overview
Table 70. ArcherDX Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. ArcherDX Business Overview
Table 72. ArcherDX SWOT Analysis
Table 73. ArcherDX Recent Developments
Table 74. ARUP Laboratories Basic Information
Table 75. ARUP Laboratories Minimal Residual Disease Testing Product Overview
Table 76. ARUP Laboratories Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. ARUP Laboratories Business Overview
Table 78. ARUP Laboratories SWOT Analysis
Table 79. ARUP Laboratories Recent Developments
Table 80. Asuragen Basic Information
Table 81. Asuragen Minimal Residual Disease Testing Product Overview
Table 82. Asuragen Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Asuragen Business Overview
Table 84. Asuragen Recent Developments
Table 85. F. Hoffmann-La Roche Basic Information
Table 86. F. Hoffmann-La Roche Minimal Residual Disease Testing Product Overview
Table 87. F. Hoffmann-La Roche Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. F. Hoffmann-La Roche Business Overview
Table 89. F. Hoffmann-La Roche Recent Developments
Table 90. Guardant Health Basic Information
Table 91. Guardant Health Minimal Residual Disease Testing Product Overview
Table 92. Guardant Health Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Guardant Health Business Overview
Table 94. Guardant Health Recent Developments
Table 95. Labcorp Basic Information
Table 96. Labcorp Minimal Residual Disease Testing Product Overview
Table 97. Labcorp Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Labcorp Business Overview
Table 99. Labcorp Recent Developments
Table 100. NeoGenomics Laboratories Basic Information
Table 101. NeoGenomics Laboratories Minimal Residual Disease Testing Product Overview
Table 102. NeoGenomics Laboratories Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. NeoGenomics Laboratories Business Overview
Table 104. NeoGenomics Laboratories Recent Developments
Table 105. Sysmex Corporation Basic Information
Table 106. Sysmex Corporation Minimal Residual Disease Testing Product Overview
Table 107. Sysmex Corporation Minimal Residual Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Sysmex Corporation Business Overview
Table 109. Sysmex Corporation Recent Developments
Table 110. Global Minimal Residual Disease Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 111. Global Minimal Residual Disease Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Minimal Residual Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 113. North America Minimal Residual Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Minimal Residual Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 115. Europe Minimal Residual Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Minimal Residual Disease Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 117. Asia Pacific Minimal Residual Disease Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Minimal Residual Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 119. South America Minimal Residual Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Minimal Residual Disease Testing Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Minimal Residual Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Minimal Residual Disease Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 123. Global Minimal Residual Disease Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Minimal Residual Disease Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 125. Global Minimal Residual Disease Testing Sales (K Units) Forecast by Application (2026-2035)
Table 126. Global Minimal Residual Disease Testing Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Minimal Residual Disease Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Minimal Residual Disease Testing Market Size (M USD), 2025-2035
Figure 5. Global Minimal Residual Disease Testing Market Size (M USD) (2020-2035)
Figure 6. Global Minimal Residual Disease Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Minimal Residual Disease Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Minimal Residual Disease Testing Product Life Cycle
Figure 13. Minimal Residual Disease Testing Sales Share by Manufacturers in 2025
Figure 14. Global Minimal Residual Disease Testing Revenue Share by Manufacturers in 2025
Figure 15. Minimal Residual Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Minimal Residual Disease Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Minimal Residual Disease Testing Revenue in 2025
Figure 18. Industry Chain Map of Minimal Residual Disease Testing
Figure 19. Global Minimal Residual Disease Testing Market PEST Analysis
Figure 20. Global Minimal Residual Disease Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Minimal Residual Disease Testing Market Share by Type
Figure 27. Sales Market Share of Minimal Residual Disease Testing by Type (2020-2025)
Figure 28. Sales Market Share of Minimal Residual Disease Testing by Type in 2025
Figure 29. Market Share of Minimal Residual Disease Testing by Type (2020-2025)
Figure 30. Market Share of Minimal Residual Disease Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Minimal Residual Disease Testing Market Share by Application
Figure 33. Global Minimal Residual Disease Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Minimal Residual Disease Testing Sales Market Share by Application in 2025
Figure 35. Global Minimal Residual Disease Testing Market Share by Application (2020-2025)
Figure 36. Global Minimal Residual Disease Testing Market Share by Application in 2025
Figure 37. Global Minimal Residual Disease Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Minimal Residual Disease Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Minimal Residual Disease Testing Market Size by Region (2020-2025)
Figure 40. North America Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Minimal Residual Disease Testing Sales Market Share by Country in 2024
Figure 43. North America Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Minimal Residual Disease Testing Market Size by Country in 2024
Figure 45. U.S. Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Minimal Residual Disease Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Minimal Residual Disease Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Minimal Residual Disease Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Minimal Residual Disease Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Minimal Residual Disease Testing Sales Market Share by Country in 2024
Figure 53. Europe Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Minimal Residual Disease Testing Market Size by Country in 2024
Figure 55. Germany Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Minimal Residual Disease Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Minimal Residual Disease Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Minimal Residual Disease Testing Market Size by Region in 2024
Figure 68. China Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Minimal Residual Disease Testing Sales and Growth Rate (K Units)
Figure 79. South America Minimal Residual Disease Testing Sales Market Share by Country in 2024
Figure 80. South America Minimal Residual Disease Testing Market Size and Growth Rate (M USD)
Figure 81. South America Minimal Residual Disease Testing Market Size by Country in 2024
Figure 82. Brazil Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Minimal Residual Disease Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Minimal Residual Disease Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Minimal Residual Disease Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Minimal Residual Disease Testing Market Size by Region in 2024
Figure 92. Saudi Arabia Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Minimal Residual Disease Testing Production Market Share by Region (2020-2025)
Figure 103. North America Minimal Residual Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Minimal Residual Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Minimal Residual Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Minimal Residual Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Minimal Residual Disease Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Minimal Residual Disease Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Minimal Residual Disease Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Minimal Residual Disease Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global Minimal Residual Disease Testing Sales Forecast by Application (2026-2035)
Figure 112. Global Minimal Residual Disease Testing Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Minimal Residual Disease Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Minimal Residual Disease Testing Market Size (M USD), 2025-2035
Figure 5. Global Minimal Residual Disease Testing Market Size (M USD) (2020-2035)
Figure 6. Global Minimal Residual Disease Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Minimal Residual Disease Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Minimal Residual Disease Testing Product Life Cycle
Figure 13. Minimal Residual Disease Testing Sales Share by Manufacturers in 2025
Figure 14. Global Minimal Residual Disease Testing Revenue Share by Manufacturers in 2025
Figure 15. Minimal Residual Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Minimal Residual Disease Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Minimal Residual Disease Testing Revenue in 2025
Figure 18. Industry Chain Map of Minimal Residual Disease Testing
Figure 19. Global Minimal Residual Disease Testing Market PEST Analysis
Figure 20. Global Minimal Residual Disease Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Minimal Residual Disease Testing Market Share by Type
Figure 27. Sales Market Share of Minimal Residual Disease Testing by Type (2020-2025)
Figure 28. Sales Market Share of Minimal Residual Disease Testing by Type in 2025
Figure 29. Market Share of Minimal Residual Disease Testing by Type (2020-2025)
Figure 30. Market Share of Minimal Residual Disease Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Minimal Residual Disease Testing Market Share by Application
Figure 33. Global Minimal Residual Disease Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Minimal Residual Disease Testing Sales Market Share by Application in 2025
Figure 35. Global Minimal Residual Disease Testing Market Share by Application (2020-2025)
Figure 36. Global Minimal Residual Disease Testing Market Share by Application in 2025
Figure 37. Global Minimal Residual Disease Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Minimal Residual Disease Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Minimal Residual Disease Testing Market Size by Region (2020-2025)
Figure 40. North America Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Minimal Residual Disease Testing Sales Market Share by Country in 2024
Figure 43. North America Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Minimal Residual Disease Testing Market Size by Country in 2024
Figure 45. U.S. Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Minimal Residual Disease Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Minimal Residual Disease Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Minimal Residual Disease Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Minimal Residual Disease Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Minimal Residual Disease Testing Sales Market Share by Country in 2024
Figure 53. Europe Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Minimal Residual Disease Testing Market Size by Country in 2024
Figure 55. Germany Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Minimal Residual Disease Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Minimal Residual Disease Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Minimal Residual Disease Testing Market Size by Region in 2024
Figure 68. China Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Minimal Residual Disease Testing Sales and Growth Rate (K Units)
Figure 79. South America Minimal Residual Disease Testing Sales Market Share by Country in 2024
Figure 80. South America Minimal Residual Disease Testing Market Size and Growth Rate (M USD)
Figure 81. South America Minimal Residual Disease Testing Market Size by Country in 2024
Figure 82. Brazil Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Minimal Residual Disease Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Minimal Residual Disease Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Minimal Residual Disease Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Minimal Residual Disease Testing Market Size by Region in 2024
Figure 92. Saudi Arabia Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Minimal Residual Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Minimal Residual Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Minimal Residual Disease Testing Production Market Share by Region (2020-2025)
Figure 103. North America Minimal Residual Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Minimal Residual Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Minimal Residual Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Minimal Residual Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Minimal Residual Disease Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Minimal Residual Disease Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Minimal Residual Disease Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Minimal Residual Disease Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global Minimal Residual Disease Testing Sales Forecast by Application (2026-2035)
Figure 112. Global Minimal Residual Disease Testing Market Share Forecast by Application (2026-2035)
